153 related articles for article (PubMed ID: 20859426)
1. How I treat mantle cell lymphoma.
Straus DJ
J Oncol Pract; 2007 Sep; 3(5):281-2. PubMed ID: 20859426
[No Abstract] [Full Text] [Related]
2. Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
Zoellner AK; Unterhalt M; Stilgenbauer S; Hübel K; Thieblemont C; Metzner B; Topp M; Truemper L; Schmidt C; Bouabdallah K; Krauter J; Lenz G; Dürig J; Vergote V; Schäfer-Eckart K; André M; Kluin-Nelemans HC; van Hoof A; Klapper W; Hiddemann W; Dreyling M; Hoster E;
Lancet Haematol; 2021 Sep; 8(9):e648-e657. PubMed ID: 34450102
[TBL] [Abstract][Full Text] [Related]
3. NF-κB signaling and its relevance to the treatment of mantle cell lymphoma.
Balaji S; Ahmed M; Lorence E; Yan F; Nomie K; Wang M
J Hematol Oncol; 2018 Jun; 11(1):83. PubMed ID: 29907126
[TBL] [Abstract][Full Text] [Related]
4. Unmet needs in the treatment of mantle cell lymphoma.
Rosen ST; Link BK; Fowler NH
Clin Adv Hematol Oncol; 2013 Nov; 11(11 Suppl 18):1-19. PubMed ID: 24893041
[TBL] [Abstract][Full Text] [Related]
5. Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1-1b study.
Davids MS; Kim HT; Nicotra A; Savell A; Francoeur K; Hellman JM; Bazemore J; Miskin HP; Sportelli P; Stampleman L; Maegawa R; Rueter J; Boruchov AM; Arnason JE; Jacobson CA; Jacobsen ED; Fisher DC; Brown JR;
Lancet Haematol; 2019 Jan; 6(1):e38-e47. PubMed ID: 30558987
[TBL] [Abstract][Full Text] [Related]
6. Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Dreyling M; Jurczak W; Jerkeman M; Silva RS; Rusconi C; Trneny M; Offner F; Caballero D; Joao C; Witzens-Harig M; Hess G; Bence-Bruckler I; Cho SG; Bothos J; Goldberg JD; Enny C; Traina S; Balasubramanian S; Bandyopadhyay N; Sun S; Vermeulen J; Rizo A; Rule S
Lancet; 2016 Feb; 387(10020):770-8. PubMed ID: 26673811
[TBL] [Abstract][Full Text] [Related]
7. Recurrent mantle cell lymphoma in the uterine cervix: a case report.
Santangelo G; Palaia I; Perniola G; Di Pinto A; Musella A; Tomao F; Fischetti M; Sassu C; Piccioni M; Di Donato V; Benedetti Panici P
J Med Case Rep; 2020 Sep; 14(1):138. PubMed ID: 32873335
[TBL] [Abstract][Full Text] [Related]
8. Health resource utilization and costs of care for adult patients with relapsed or refractory mantle cell lymphoma in the United States: a retrospective claims analysis.
Ito D; Feng C; Fu C; Kim C; Wu J; Epstein J; Snider JT; DuVall AS
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):773-787. PubMed ID: 37278284
[TBL] [Abstract][Full Text] [Related]
9. Mantle cell lymphoma disguised as marginal zone lymphoma.
Jacobson E; Burke P; Tindle BH
Arch Pathol Lab Med; 2005 Jul; 129(7):929-32. PubMed ID: 15974819
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma presenting as acute appendicitis.
Chae M; Kumar S; Cheema M
Int J Surg Case Rep; 2015; 6C():33-5. PubMed ID: 25506848
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-induced redistribution lymphocytosis in mantle cell lymphoma with hyaline vascular Castleman disease-like features.
Togitani K; Iguchi M; Asagiri T; Ogasawara F; Murakami I; Kojima K
J Clin Exp Hematop; 2022 Mar; 62(1):46-51. PubMed ID: 34707036
[TBL] [Abstract][Full Text] [Related]
12. Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Trněný M; Lamy T; Walewski J; Belada D; Mayer J; Radford J; Jurczak W; Morschhauser F; Alexeeva J; Rule S; Afanasyev B; Kaplanov K; Thyss A; Kuzmin A; Voloshin S; Kuliczkowski K; Giza A; Milpied N; Stelitano C; Marks R; Trümper L; Biyukov T; Patturajan M; Bravo MC; Arcaini L;
Lancet Oncol; 2016 Mar; 17(3):319-331. PubMed ID: 26899778
[TBL] [Abstract][Full Text] [Related]
13. Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma.
Henson SE; Morford T; Stein MP; Wall R; Malone CS
Acta Histochem; 2011 Nov; 113(7):729-42. PubMed ID: 21145576
[TBL] [Abstract][Full Text] [Related]
14. Mimicking an Intraluminal Lesion: A Case Report on Mantle Cell Lymphoma.
Ezeh KJ; Ezeudemba O
Cureus; 2021 Oct; 13(10):e18870. PubMed ID: 34804720
[TBL] [Abstract][Full Text] [Related]
15. Image analytic study of nuclear area in mantle cell lymphoma.
Baek T; Huh J; Kwak H; Park M; Lee H
Korean J Hematol; 2010 Sep; 45(3):193-6. PubMed ID: 21120209
[TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma: advances in biology and therapy.
Smith MR
Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma?
Bassarova A; Tierens A; Lauritzsen GF; Fosså A; Delabie J
Virchows Arch; 2008 Oct; 453(4):407-11. PubMed ID: 18696109
[TBL] [Abstract][Full Text] [Related]
18. Mantle cell lymphoma with involvement of the digestive tract.
Oña-Ortiz FM; Sánchez-Del Monte J; Ramírez-Solís ME; de la Mora-Levy JG; Alonso-Larraga JO; Lino-Silva LS; Herrera-Servín MA; Jiménez-Morales M; Manzano-Robleda MC; Yañez-Cruz M; Hernández-Guerrero AI
Rev Gastroenterol Mex (Engl Ed); 2019; 84(4):434-441. PubMed ID: 30217675
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Mantle Cell Lymphoma Presenting as Gastrointestinal Bleeding.
Ahmed R; Kumar K; Makker J; Niazi M; Balar B
Case Rep Gastroenterol; 2018; 12(2):379-384. PubMed ID: 30186088
[TBL] [Abstract][Full Text] [Related]
20. Transformation of indolent mantle cell lymphoma to pleomorphic mantle cell lymphoma: case report and review of clinical and morphologic variants.
Kiel MJ; Smith LB
Arch Pathol Lab Med; 2012 Aug; 136(8):871-5. PubMed ID: 22849733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
